Data / Drug companies / Sevelamer carbonate
Sevelamer carbonate: 35 companies and 51 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sevelamer carbonate is listed in the FDA National Drug Code Directory by 35 companies, with 51 products in commercial distribution. 44 of the products (86.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; powder, for suspension; tablet, and the newest product started marketing on May 21, 2026.
The request: Get every company that lists sevelamer carbonate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 35
- Products
- 51
- Generic (ANDA) products
- 44 (86.3%)
- Application numbers
- 18
- Routes
- Oral
- Brand names
- Renvela
- openFDA record search
- api.fda.gov
Companies that list sevelamer carbonate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Sanofi-Aventis U.S. LLC | 4 | powder, for suspension; tablet, film coated | Authorized generics (NDA) | July 14, 2023 |
| Aurobindo Pharma Limited | 3 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | July 17, 2017 |
| Genzyme Corporation | 3 | powder, for suspension; tablet, film coated | New drug applications (NDA) | August 12, 2009 |
| Macleods Pharmaceuticals Limited | 3 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | April 26, 2024 |
| Strides Pharma Science Limited | 3 | for suspension; tablet | Generic drugs (ANDA) | July 2, 2024 |
| Amneal Pharmaceuticals of New York LLC | 2 | powder, for suspension | Generic drugs (ANDA) | November 20, 2020 |
| Bionpharma Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | September 1, 2021 |
| Cardinal Health 107, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | September 29, 2017 |
| Cipla USA Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | October 26, 2017 |
| Exelan Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | November 8, 2017 |
| AiPing Pharmaceutical, Inc. | 1 | tablet | Generic drugs (ANDA) | December 15, 2025 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | August 22, 2017 |
| Amneal Pharmaceuticals LLC | 1 | tablet, film coated | Generic drugs (ANDA) | November 28, 2017 |
| Atlantic Biologicals Corp. | 1 | tablet, film coated | Generic drugs (ANDA) | June 27, 2018 |
| AvKARE | 1 | tablet, film coated | Generic drugs (ANDA) | October 19, 2025 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | January 14, 2019 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | April 19, 2023 |
| Dr. Reddy's Laboratories Limited | 1 | tablet, film coated | Generic drugs (ANDA) | September 29, 2017 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 29, 2017 |
| Insignamedex LLC | 1 | tablet, film coated | Generic drugs (ANDA) | May 21, 2026 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | September 29, 2017 |
| Marp Pharma | 1 | tablet, film coated | Generic drugs (ANDA) | May 1, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet, film coated | Generic drugs (ANDA) | July 17, 2017 |
| Navinta LLC | 1 | tablet, film coated | Generic drugs (ANDA) | November 1, 2025 |
| NorthStar Rx LLC | 1 | tablet, film coated | Generic drugs (ANDA) | June 6, 2018 |
| NorthStar RxLLC | 1 | powder, for suspension | Generic drugs (ANDA) | January 1, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | December 15, 2025 |
| Precision Dose, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 23, 2021 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | September 30, 2019 |
| Shandong Xinhua Pharmaceutical Company Limited | 1 | tablet, film coated | Generic drugs (ANDA) | February 27, 2025 |
| Upsher-Smith Laboratories, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 30, 2019 |
| Westminster Pharmaceuticals, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 23, 2025 |
| Zydus Lifesciences Limited | 1 | tablet, film coated | Generic drugs (ANDA) | September 17, 2020 |
| Zydus Pharmaceuticals USA Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 17, 2020 |
| Zydus Pharmaceuticals USA Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | April 1, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 33 | 64.7% |
| Powder, for suspension | 13 | 25.5% |
| Tablet | 3 | 5.9% |
| For suspension | 2 | 3.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 44 | 86.3% |
| Authorized generics (NDA) | 4 | 7.8% |
| New drug applications (NDA) | 3 | 5.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Phosphate Binder | 51 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.